Seagen's breast cancer therapy meets main goal in late-stage study
16/08/2023 13:09
Aug 16 (Reuters) - Seagen SGEN.O said on Wednesday its cancer therapy in combination with Roche's ROG.S Kadcyla helped control disease progression in a late-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Maju Samuel) ((Mariam.ESunny@thomsonreuters.com;))